 |
||
|---|---|---|
| 【ProductName】 |
ZFP36L2 Antibody Blocking Peptide |
|
| 【Cat NO.】 |
K108935P-Ag |
|
| 【Source】 |
Synthetic |
|
| 【Storage】 |
Store at -20℃，2 years.Avoid freeze/thaw cycles. |
|
| 【Appearance】 |
Lyophilized powder |
|
| 【Swiss Prot】 |
P47974 |
|
| 【Gene ID】 |
678 |
|
| 【Application】 |
Blocking Peptide of K108935P Antibody |
|
| 【Purification】 |
HPLC |
|
| 【Activity】 |
Not tested |
|
| 【Note】 |
Please allow the product to equilibrate to room temperature in a dry environment before opening the packaging. |
|
|
||
Background：
Zinc-finger RNA-binding protein that destabilizes several cytoplasmic AU-rich element (ARE)-containing mRNA transcripts by promoting their poly(A) tail removal or deadenylation， and hence provide a mechanism for attenuating protein synthesis (PubMed:25106868， PubMed:14981510). Acts as a 3’-untranslated region (UTR) ARE mRNA-binding adapter protein to communicate signaling events to the mRNA decay machinery (PubMed:25106868). Functions by recruiting the CCR4-NOT deadenylase complex and probably other components of the cytoplasmic RNA decay machinery to the bound ARE-containing mRNAs， and hence promotes ARE-mediated mRNA deadenylation and decay processes (PubMed:25106868). Binds to 3’-UTR ARE of numerous mRNAs (PubMed:20506496， PubMed:25106868， PubMed:14981510). Promotes ARE-containing mRNA decay of the low-density lipoprotein (LDL) receptor (LDLR) mRNA in response to phorbol 12-myristate 13-acetate (PMA) treatment in a p38 MAPK-dependent manner (PubMed:25106868). Positively regulates early adipog